Stay updated on Troriluzole for Spinocerebellar Ataxia Clinical Trial
Sign up to get notified when there's something new on the Troriluzole for Spinocerebellar Ataxia Clinical Trial page.

Latest updates to the Troriluzole for Spinocerebellar Ataxia Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedNew revision: v3.3.3 is now listed in the study record history, and the HHS Vulnerability Disclosure link and the Revision: v3.3.2 item were removed from the footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check29 days agoNo Change Detected
- Check36 days agoChange DetectedA new site revision entry 'Revision: v3.3.2' was added to the history, replacing the previous 'Revision: v3.3.1'.SummaryDifference0.1%

- Check43 days agoChange DetectedA new revision (v3.3.1) was added and an older revision (v3.2.0) was removed from the Record History, reflecting internal version updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check51 days agoChange DetectedRemoved the government funding operating-status notice that previously appeared on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check58 days agoChange DetectedNew version 52 on 2025-10-19 introduces updated Study Status in the record history, and an earlier 2025-02-10 entry was removed.SummaryDifference0.2%

- Check65 days agoChange DetectedThe new screenshot shows multiple updates to the study history, including changes to Study Status and Contacts/Locations across several versions. Additional updates to sections like Study Design and Eligibility appear as the record progresses.SummaryDifference0.1%

Stay in the know with updates to Troriluzole for Spinocerebellar Ataxia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Troriluzole for Spinocerebellar Ataxia Clinical Trial page.